Cancer BiologyInternational Journal of Radiation Oncology*Biology*PhysicsPeer-reviewed
MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer
Shrey Ramesh, Ahmet Cifci, Saahil Javeri…·Andrew M. Baschnagel
This study shows that capmatinib radiosensitizes MET exon 14-mutated and MET-amplified NSCLC cells and tumors, inhibiting DNA repair and reducing tumor growth.
11 citations